Why PFO Closure is an Exciting Therapy Megan Coylewright, MD MPH - - PowerPoint PPT Presentation

why pfo closure is an
SMART_READER_LITE
LIVE PREVIEW

Why PFO Closure is an Exciting Therapy Megan Coylewright, MD MPH - - PowerPoint PPT Presentation

Why PFO Closure is an Exciting Therapy Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center Disclosures Edwards LifeSciences Boston Scientific


slide-1
SLIDE 1

Why PFO Closure is an Exciting Therapy

Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center

slide-2
SLIDE 2

Disclosures

  • Edwards LifeSciences
  • Boston Scientific
  • Gore
slide-3
SLIDE 3

PFO closure today

  • Case
  • Multiple RCTs with proven efficacy
  • Predictable and safe procedure
  • Excellent reimbursement
slide-4
SLIDE 4
  • 60 year old man with small left parietal

infarction of unclear etiology, full recovery

  • Hypertension
  • Brief tobacco use
  • Neuro partner refers for

PFO closure

slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8
  • No history cancer, personal clot or first degree relative
  • r autoimmune disease
  • CTA negative for atherosclerotic or other vessel

disease

  • Zio negative for atrial fibrillation
  • Imaging demonstrates a high risk PFO (atrial septal

aneurysm)

  • Started statin, stopped as he feels he “doesn’t need it”
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11
slide-12
SLIDE 12

PFO closure today

  • Case
  • Multiple RCTs with proven efficacy
  • Predictable and safe procedure
  • Excellent reimbursement
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

PFO closure today

  • Case
  • Multiple RCTs with proven efficacy
  • Predictable and safe procedure
  • Excellent reimbursement
slide-17
SLIDE 17
slide-18
SLIDE 18

REDUCE Study Data1 RESPECT Study Data2 Device – or procedure-related SAE 3.6% 4.2% Device-related SAE 1.4% 2.6% Procedure-related SAE 2.5% 2.4%

PFO closure is a safe procedure with low rate of device related SAEs

Short procedure and down time for patients is minimal

Total Length of procedure Back to Strenuous Activities 1-2 hours 2 weeks

slide-19
SLIDE 19

PFO closure today

  • Case
  • Multiple RCTs with proven efficacy
  • Predictable and safe procedure
  • Excellent reimbursement
slide-20
SLIDE 20

Reimbursement

Physician Reimbursement

  • CPT Code - 93580 - Percutaneous transcatheter closure of congenital interatrial

communication (ie, Fontan fenestration, atrial septal defect) with implant - $1025.31

  • wRVU – 17.97

Hospital Outpatient

  • HCPCS/CPT Code – 93580 - $16,020

Hospital Inpatient

  • ICD – 10 – PCS – 02U53JZ – MS-DRG- 273 - $21,569
  • ICD – 10 – PCS – 02U54JZ – MS –DRG – 274 - $16,684
slide-21
SLIDE 21
slide-22
SLIDE 22
slide-23
SLIDE 23

https://www.bmj.com/conten t/362/bmj.k2515/infographic

slide-24
SLIDE 24
slide-25
SLIDE 25

Megan Coylewright, MD MPH Interventional Cardiology Associate Director, Structural Heart Disease Program Dartmouth-Hitchcock Medical Center megan.coylewright@hitchcock.org